Cargando…

Treatment with CBA-NP a novel chimeric natriuretic peptide attenuates cardiorenal fibrosis and improves diastolic dysfunction in diabetic rat model

Detalles Bibliográficos
Autores principales:	Ameenuddin, Syed, Oehler, Elise A, Burnett, John C, Chen, Horng H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363212/ http://dx.doi.org/10.1186/1471-2210-11-S1-P2

Ejemplares similares

A biodegradable in-situ polymer precipitation delivery system for sustained delivery of a novel chimeric natriuretic peptide CD-NP in an experimental model of myocardial infarction
por: Lim, Soo Ghim, et al.
Publicado: (2013)

AC-NP: A Novel Chimeric Peptide with Natriuretic and Vasorelaxing Actions
por: Chen, Bao-Ying, et al.
Publicado: (2011)

Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction
por: Luers, Claus, et al.
Publicado: (2010)

Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence
por: Koratala, Abhilash, et al.
Publicado: (2017)

A novel designer natriuretic peptide CD-NP suppresses TGF-beta 1 induced collagen Type I production in human cardiac fibroblasts
por: Ichiki, Tomoko, et al.
Publicado: (2009)

Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolism
por: Glöde, Anja, et al.
Publicado: (2017)

Mutation of three amino acids in the disulfide-ring of a CNP based chimeric natriuretic peptide alters its vascular properties
por: Chen, Horng H, et al.
Publicado: (2009)

Chronic natriuretic peptide protein therapeutics
por: Chen, Horng H, et al.
Publicado: (2013)

Sepsis-associated diastolic dysfunction without elevated plasma B-type natriuretic peptide
por: Sturgess, DJ, et al.
Publicado: (2008)

Krait natriuretic peptide (KNP): a non-classical NP
por: Sridharan, Sindhuja, et al.
Publicado: (2013)

A Functional Genetic Variant (N521D) in Natriuretic Peptide Receptor 3 Is Associated with Diastolic Dysfunction: The Prevalence of Asymptomatic Ventricular Dysfunction Study
por: Pereira, Naveen L., et al.
Publicado: (2014)

Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage
por: Garcia-Alvarez, Ana, et al.
Publicado: (2010)

Association of N- terminal Pro Brain Natriuretic Peptide with Echocardiographic Measures of Diastolic Dysfunction in Cirrhosis
por: Singh, Ajmera Jail, et al.
Publicado: (2020)

B-type natriuretic peptide single nucleotide polymorphism rs198389 and survival in the general community
por: Boerrigter, Guido, et al.
Publicado: (2009)

Induction of partial chimerism in nonirradiated B-lymphocyte-deficient CBA/N mice
Publicado: (1978)

Diastolic dysfunction in septic shock is an independent predictor of elevated B-type natriuretic peptide and hospital mortality
por: Sturgess, D, et al.
Publicado: (2010)

Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides
por: Romano, Silvio, et al.
Publicado: (2010)

Diastolic but not systolic dysfunction is associated with troponin and N-terminal pro-brain natriuretic peptide elevation in sepsis
por: Landesberg, G, et al.
Publicado: (2009)

Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac hypertrophy and cardiorenal fibrosis induced by uremic toxins: Implications for cardiorenal syndrome
por: Savira, Feby, et al.
Publicado: (2017)

B-type natriuretic peptide single nucleotide polymorphism rs198389 is highly prevalent and impacts test characteristics of common assays
por: Costello-Boerrigter, Lisa C, et al.
Publicado: (2009)

Natriuretic peptide pathways in heart failure: further therapeutic possibilities
por: Sangaralingham, S Jeson, et al.
Publicado: (2022)

Interstitial Fibrosis and Diastolic Dysfunction in Aortic Stenosis
por: Canty, John M., et al.
Publicado: (2020)

Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling
por: Lee, Seul-Gee, et al.
Publicado: (2022)

Natriuretic peptides for the detection of diastolic dysfunction and heart failure with preserved ejection fraction—a systematic review and meta-analysis
por: Remmelzwaal, Sharon, et al.
Publicado: (2020)

In-Vivo Evaluation of an In Situ Polymer Precipitation Delivery System for a Novel Natriuretic Peptide
por: Lim, Soo Ghim, et al.
Publicado: (2013)

Cardiac Spinal Afferent Denervation Attenuates Renal Dysfunction in Rats With Cardiorenal Syndrome Type 2
por: Xia, Zhiqiu, et al.
Publicado: (2022)

Cenderitide, a novel dual GC-A and GC-B receptor activator, is a potent chronic cardiorenal fibroinhibiting peptide which suppresses aldosterone and reduces proteinuria in models of ardiorenal fibrosis
por: Martin, Fernando L, et al.
Publicado: (2011)

The novel dual GC-A and GC-B designer natriuretic peptide, cenderitide (CD-NP), enhances the renal actions of furosemide in a model of severe heart failure
por: Costello-Boerrigter, Lisa C, et al.
Publicado: (2011)

Natriuretic Peptides in Assessment of Ventricular Dysfunction
por: Gorenjak, Maksimiljan
Publicado: (2003)

Innovative Therapeutics: Designer Natriuretic Peptides
por: Meems, Laura M.G., et al.
Publicado: (2016)

Glucocorticoids ameliorate cardiorenal syndrome through the NPR1/SGK1 pathway in natriuretic peptide receptor A‑heterozygous mice
por: Huang, Yao-Meng, et al.
Publicado: (2023)

Cardiorenal Effects of Long‐Term Phosphodiesterase V Inhibition in Pre–Heart Failure
por: Hubers, Scott A., et al.
Publicado: (2022)

The Importance of Natriuretic Peptides in Cardiometabolic Diseases
por: Vinnakota, Shravya, et al.
Publicado: (2020)

A New Chimeric Natriuretic Peptide, C(N)AA(C), for the Treatment of Left Ventricular Dysfunction after Myocardial Infarction
por: Zhang, Shu-Miao, et al.
Publicado: (2017)

Fibrosis, the Bad Actor in Cardiorenal Syndromes: Mechanisms Involved
por: Delgado-Valero, Beatriz, et al.
Publicado: (2021)

Insulin Therapy is Associated With Increased Myocardial Interstitial Fibrosis and Cardiomyocyte Apoptosis in a Rodent Model of Experimental Diabetes
por: Adel, Fadi W., et al.
Publicado: (2022)

Brookhaven: All the way with CBA
Publicado: (1983)

Extracorporeal shock wave treatment attenuated left ventricular dysfunction and remodeling in mini-pig with cardiorenal syndrome
por: Sheu, Jiunn-Jye, et al.
Publicado: (2017)

CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome
por: Zheng, Cankun, et al.
Publicado: (2022)

C-type natriuretic peptide chronic administration attenuates cardiac fibrosis and inflammation in spontaneously hypertensive rats
por: Prentki, E Santos, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k2snocugjoq43ckjbnk85amidn